- Home
- CLDX vs NVTS Comparison
CLDX vs NVTS Comparison
Compare CLDX & NVTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLDX | NVTS |
|---|---|---|
| Founded | N/A | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.0B |
| IPO Year | 1995 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CLDX | NVTS |
|---|---|---|
| Price | $38.90 | $11.60 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 5 |
| Target Price | ★ $46.60 | $6.68 |
| AVG Volume (30 Days) | 694.0K | ★ 11.6M |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $12,743,000.00 | ★ $45,916,000.00 |
| Revenue This Year | $111.39 | N/A |
| Revenue Next Year | $235.85 | $71.28 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 87.78 | N/A |
| 52 Week Low | $22.10 | $5.83 |
| 52 Week High | $45.14 | $34.17 |
Technical Indicators
Market Signals| Indicator | CLDX | NVTS |
|---|---|---|
| Relative Strength Index (RSI) | 44.63 | 43.52 |
| Support Level | $28.51 | $10.77 |
| Resistance Level | $40.30 | $14.95 |
| Average True Range (ATR) | 1.37 | 0.67 |
| MACD | -0.36 | -0.00 |
| Stochastic Oscillator | 9.94 | 31.82 |
Price Performance
Historical ComparisonAbout CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About NVTS Navitas Semiconductor Corporation
Navitas Semiconductor Corp develops ultra-efficient gallium nitride (GaN) semiconductors that are revolutionizing power electronics. GaN power ICs integrate GaN power with drive, control, and protection to enable fast charging, high power density, and energy savings for mobile, consumer, enterprise, eMobility, and new energy markets. The company operates as one reportable segment, the design, development, manufacture, and marketing of integrated circuits and related components. Geographically, the company operates in Hong Kong, China, Europe, the United States, Rest of Asia, and Others. The majority of revenue is generated from Hong Kong.